poisar

Stock

Zura Bio Limited ZURA

$5.85-2.50%

Overview

ZURA market data

Price History

ZURA price chart · 1M
O
6.00
H
6.01
L
5.84
C
5.85
Vol
40,752.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$6.00
Previous Close
$6.00
Day High
$6.01
Day Low
$5.84
52 Week High
$7.02
52 Week Low
$3.29
7 Day Return
+1.83%
30 Day Return
+5.79%
90 Day Return
+36.05%
1 Year Return
+16.65%
Daily Notional Volume
$238.4K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.72
Diluted earnings per share over the trailing twelve months.
Beta
-0.05
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.88 – $7.44
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $566.8M · P/B 1.11.

Company News

8 captured
8-K filing — Zura Bio Ltd (ZURA)SEC EDGAR · Aug 17, 2026, 11:00 AM
Wedbush Maintains Outperform on Zura Bio, Raises Price Target to $22Benzinga · Aug 12, 2026, 4:00 PM
Guggenheim Maintains Buy on Zura Bio, Raises Price Target to $20Benzinga · Aug 12, 2026, 12:28 PM
Zura Bio Q2 EPS $(0.21) Misses $(0.20) EstimateBenzinga · Aug 11, 2026, 11:43 AM
William Blair Initiates Coverage On Zura Bio with Outperform RatingBenzinga · Jul 8, 2026, 7:00 PM
Analyst Sees Multi-Billion-Dollar Sales Potential for Zura Bio’s Lead TherapyBenzinga · Jul 8, 2026, 5:30 PM
Wedbush Reiterates Outperform on Zura Bio, Maintains $15 Price TargetBenzinga · Jul 1, 2026, 2:05 PM
Zura Bio Completes Enrollment In Phase 2 TibuSHIELD Trial of Tibulizumab in Adults With HSBenzinga · Jun 29, 2026, 11:35 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock